PubMed COVID-19 Clinical Care

CONCLUSIONS: SARS-CoV-2 can lead to neurological complications, such as cerebrovascular manifestations, motor movement complications, and cognitive decline. COVID-19 infection can result in cerebrovascular symptoms and diseases, such as strokes and

Currently circulating SARS-CoV-2 variants have acquired convergent mutations at hot spots in the receptor-binding domain¹ (RBD) of the spike protein. The effects of these mutations on viral infection and transmission and the efficacy of vaccines and

The health crisis caused by the COVID-19 pandemic has negatively influenced the work of health staff, especially nurses. Stressors that affect nurses have been intensified and new stressors have also emerged, threatening their well-being and job

The COVID-19 pandemic has been blamed for multiple health system problems. Many of the current issues, including staffing shortages, while exacerbated by the epidemic, have plagued us for decades. Various reactionary solutions to nursing shortages

Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations

CONCLUSION: In direct comparisons, grade of suspected seizure severity was lower in the Non-1st Group than in the 1st Group.

No abstract

Community-based organizations (CBOs) are on the frontlines offering resources and support to residents during times of distress. Through a community-academic partnership, an interdisciplinary team developed, collected, and analyzed 91 surveys from

The SARS-CoV-2 main protease (M^(pro)) is the drug target of Pfizer's oral drug nirmatrelvir. The emergence of SARS-CoV-2 variants with mutations in M^(pro) raised the alarm of potential drug resistance. To identify potential clinically relevant drug

CONCLUSION: Neurological symptoms were observed in more than 91% of the patients, while neurological signs were present in 10.5% of the COVID-19 patients. Additionally, positive troponin, WBC≥15,000, and a history of respiratory disease were the